cbdMD Inc (YCBD)

Currency in USD
1.660
+0.290(+21.17%)
Closed·
1.6600.000(0.00%)
·
Unusual Post-Market activity
YCBD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.3201.760
52 wk Range
0.4706.538
Key Statistics
Prev. Close
1.66
Open
1.33
Day's Range
1.32-1.76
52 wk Range
0.47-6.538
Volume
8.87M
Average Volume (3m)
13.67M
1-Year Change
-39.37%
Book Value / Share
0.81
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
YCBD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
2.000
Upside
+20.48%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

cbdMD Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

cbdMD Inc Company Profile

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products, include CDB tinctures, gummies, topicals, capsules, drink mixes, ready to drink cans, and sleep, focus, and calming aids. It also provides veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solutions under the hempMD brand. It distributes its products through its e-commerce website, third-party e-commerce sites, select distributors and marketing partners, wholesalers, and various brick and mortar retailers. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is headquartered in Charlotte, North Carolina.

Employees
42

cbdMD Inc Earnings Call Summary for Q4/2025

  • CBDMD reported Q4 2025 net sales of $19.1 million (down from $19.5 million in 2024), while reducing operating loss to $2.1 million from $3.3 million and improving gross margin to 63%.
  • Stock plummeted 21.76% in aftermarket trading following the earnings announcement, reflecting investor concerns over negative EPS forecasts for upcoming quarters.
  • CEO Ronan Kennedy stated the 'heavy lifting of the turnaround is largely behind us' as the company focuses on expanding its Oasis beverage brand and direct-to-consumer growth.
  • The company is preparing for potential Medicare CBD coverage starting in April, which could involve 60 million consumers and $30 billion in potential spending.
  • Wholesale business grew from $3.8 million to $4.5 million, offsetting a 6% decline in e-commerce sales as the company improved its adjusted non-GAAP EBITDA to -$900,000 from -$1.7 million.
Last Updated: 2025-12-19, 05:30 p/m
Read Full Transcript

Compare YCBD to Peers and Sector

Metrics to compare
YCBD
Peers
Sector
Relationship
P/E Ratio
−3.6x−2.1x−0.6x
PEG Ratio
−0.04−0.090.00
Price/Book
2.2x1.0x2.6x
Price / LTM Sales
0.8x1.5x3.2x
Upside (Analyst Target)
20.5%78.5%41.8%
Fair Value Upside
Unlock30.6%5.1%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 2.000
(+20.48% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Maxim Group
Buy2.00+20.48%3.00MaintainAug 20, 2025

Earnings

Latest Release
Dec 19, 2025
EPS / Forecast
-0.08 / --
Revenue / Forecast
4.72M / 5.61M
EPS Revisions
Last 90 days

YCBD Income Statement

People Also Watch

2.740
BEAT
-6.48%
1.6500
SIDU
-27.95%
1.2600
ADTX
+3.28%

FAQ

What Is the cbdMD (YCBD) Stock Price Today?

The cbdMD stock price today is 1.660

What Stock Exchange Does cbdMD Trade On?

cbdMD is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for cbdMD?

The stock symbol for cbdMD is "YCBD."

What Is the cbdMD Market Cap?

As of today, cbdMD market cap is 15.64M.

What Is cbdMD's Earnings Per Share (TTM)?

The cbdMD EPS (TTM) is -1.09.

From a Technical Analysis Perspective, Is YCBD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has cbdMD Stock Split?

cbdMD has split 2 times.

How Many Employees Does cbdMD Have?

cbdMD has 42 employees.

What is the current trading status of cbdMD (YCBD)?

As of Dec 24, 2025, cbdMD (YCBD) is trading at a price of 1.660, with a previous close of 1.660. The stock has fluctuated within a day range of 1.320 to 1.760, while its 52-week range spans from 0.470 to 6.538.

What Is cbdMD (YCBD) Price Target According to Analysts?

The average 12-month price target for cbdMD is USD2, with a high estimate of USD2 and a low estimate of USD2. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +20.48% Upside potential.

What Is the YCBD After Hours Price?

YCBD's last after hours stock price is 1.760, the stock has decreased by 0.100, or 6.020%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.